Clinical Trials Browser

Phase 2 × Endometrial Hyperplasia × Tirzepatide × Clear all

NCT07349641 2026-03-17

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Hyperplasia

NCT07078838 2026-01-16

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Phase 2 Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms